| View |
|
DRP-12598-02
|
Palonosetron Hydrochloride
|
Sepalon
|
50 mcg/mL (250 mcg/mL)
|
Solution for Injection (IV)
|
Antiemetic/Antinauseant [Serotonin (5HT3) Antagonist]
|
Sichuan Huiyu Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
20 December 2023
|
12 September 2027
|
| View |
|
DRP-12601-07
|
Febuxostat
|
Bristat 40
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Sunrise International Labs Limited
|
India
|
CLIDP Conversion
|
04 January 2024
|
14 September 2027
|
| View |
|
DRP-12948-01
|
Ampicillin (as sodium)
|
Ampibet
|
250 mg
|
Powder for Solution for Injection (IM/IV)
|
Antibacterial (Beta-lactamase inhibitor)
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
04 January 2024
|
11 November 2027
|
| View |
|
DRP-12949-01
|
Ampicillin (as sodium)
|
Ampibet
|
500 mg
|
Powder for Solution for Injection (IM/IV)
|
Antibacterial (Beta-lactamase)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
CLIDP Conversion
|
05 January 2024
|
11 November 2027
|
| View |
|
DRP-12958-01
|
Sitagliptin (as phosphate monohydrate)
|
Sitaguard 100
|
100 mg
|
Film-Coated Tablet
|
Antidiabetic Agent [Dipeptidyl peptidase 4 (DPP-4) Inhibitor]
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
20 December 2023
|
09 November 2027
|
| View |
|
DRP-13115-01
|
Co-Amoxiclav
|
None
|
312.5 mg per 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillins)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
04 January 2024
|
02 December 2027
|
| View |
|
DRP-13151-05
|
Hydrocortisone (as sodium succinate)
|
Hydrocortef
|
100 mg
|
Powder for Injection (I.M./I.V.)
|
Corticosteroid for Systemic Use (Glucocorticoid)
|
Skymap Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 December 2023
|
12 December 2027
|
| View |
|
DRP-13230-04
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Sitakem-M
|
100 mg/ 1 g
|
Extended Release Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
20 December 2023
|
05 January 2028
|
| View |
|
DRP-13236-07
|
Omeprazole (as sodium)
|
Aeprazole
|
40 mg
|
Lyophilized Powder for Injection
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co. Ltd
|
China
|
CLIDP Conversion
|
04 January 2024
|
06 January 2028
|
| View |
|
DRP-13573-01
|
Rivaroxaban
|
None
|
15 mg
|
Film-Coated Tablet
|
Anticoagulant
|
Bayer AG
|
Germany
|
CLIDP Conversion
|
20 December 2023
|
25 April 2025
|
| View |
|
DRP-13576-01
|
Rivaroxaban
|
Unbranded
|
10 mg
|
Film-Coated Tablet
|
Anticoagulant
|
Bayer AG
|
Germany
|
Renewal
|
30 April 2024
|
29 April 2029
|
| View |
|
DRP-13674-03
|
Ampicillin (as sodium)
|
Eurozyllin 250
|
250 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Penicillin)
|
Uni Medicolabs, Inc
|
India
|
CLIDP Conversion
|
05 January 2024
|
24 March 2028
|
| View |
|
DRP-13682-01
|
Co-amoxiclav
|
Colav-250
|
250 mg/ 62.5 mg per 5 mL
|
Powder for Oral Suspension
|
Antibacterial (Penicillin and beta-lactamase inhibitor)
|
Giyaan Pharma Private Limited
|
India
|
CLIDP Conversion
|
24 December 2023
|
28 March 2028
|
| View |
|
DRP-13712-03
|
Moxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium)
|
Belvadox
|
5 mg/1 mg per mL (0.5% w/v / 0.1% w/v)
|
Ophthalmic Solution
|
Anti-infective (Fluoroquinolone)/ Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
20 December 2023
|
30 March 2028
|
| View |
|
DRP-13712-05
|
Moxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium)
|
Moxiflam
|
5 mg/1 mg per mL (0.5% w/v / 0.1% w/v)
|
Ophthalmic Solution
|
Anti-infective (Fluoroquinolone)/ Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
04 January 2024
|
30 March 2028
|
| View |
|
DRP-13880-01
|
Acetylcysteine
|
Gotyl 200
|
200mg
|
Granules for Oral Solution
|
Mucolytic
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
02 January 2024
|
12 May 2028
|
| View |
|
DRP-13888-01
|
Iron (as Iron Sucrose)
|
None
|
20 mg/mL (100mg/5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
20 December 2023
|
11 May 2028
|
| View |
|
DRP-13888-02
|
Iron (As Iron Sucrose)
|
Feruvin
|
20 mg/mL (100mg/5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
31 December 2023
|
11 May 2028
|
| View |
|
DRP-13888-03
|
Iron (as Iron Sucrose)
|
Bliron
|
20 mg/ mL (100 mg/ 5 mL)
|
Solution for Injection (IV)
|
Antianemic
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
04 January 2024
|
11 May 2028
|
| View |
|
DRP-14008-01
|
Cefoxitin (as sodium)
|
Foxilev
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Second Generation Cephalosporin)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
27 December 2023
|
05 June 2028
|